Cannabichromene, or CBC, is one of the numerous cannabinoids from the cannabis plant. Though most attention has been allotted to more well-known cannabinoids like THC and CBD, CBC has seen growing interest due to its potential therapeutic benefits and unique properties. First discovered in 1966, CBC is non-intoxicating, meaning that it does not create the “high” associated with THC. Instead, it works subtly, engaging with the body’s endocannabinoid system, promoting balance and well-being.
CBC primarily acts through binding with CB2 receptors, abundant in immune tissues, and also displays influences on TRPV1 and TRPA1 receptors. These interactions are linked to potential anti-inflammatory, pain-relieving, and neuroprotective effects. Some studies indicate that CBC might facilitate mood elevation, anxiolysis, or even the promotion of brain health through neurogenesis.
CBC also has the ability to produce synergy with other cannabinoids, something known as the entourage effect. What this means is that although CBC in its own right is a beneficial cannabinoid, its effects might be heightened even more when working together with THC, CBD, or terpenes.
CBC has recently become a very popular ingredient for edibles and THC-infused products alike. From tinctures and capsules to gummies, CBC-prepared products are excellent for those who need natural wellness remedies without getting “high.”
As more research is done, CBC is set to be among the front runners in the cannabis world because of its complementary benefits to other cannabinoids.
